Free Trial

National Research (NRC) Competitors

National Research logo
$14.95 -0.15 (-0.99%)
Closing price 04:00 PM Eastern
Extended Trading
$14.94 -0.01 (-0.07%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NRC vs. UPBD, TASK, GB, CRTO, FLYW, ASTH, EVH, RDWR, PRG, and STGW

Should you be buying National Research stock or one of its competitors? The main competitors of National Research include Upbound Group (UPBD), TaskUs (TASK), Global Blue Group (GB), Criteo (CRTO), Flywire (FLYW), Astrana Health (ASTH), Evolent Health (EVH), Radware (RDWR), Aaron's (PRG), and Stagwell (STGW). These companies are all part of the "business services" industry.

National Research vs. Its Competitors

National Research (NASDAQ:NRC) and Upbound Group (NASDAQ:UPBD) are both small-cap business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, media sentiment, dividends, profitability, valuation and earnings.

National Research has a net margin of 17.14% compared to Upbound Group's net margin of 2.74%. National Research's return on equity of 71.33% beat Upbound Group's return on equity.

Company Net Margins Return on Equity Return on Assets
National Research17.14% 71.33% 18.67%
Upbound Group 2.74%36.30%8.39%

National Research pays an annual dividend of $0.48 per share and has a dividend yield of 3.2%. Upbound Group pays an annual dividend of $1.56 per share and has a dividend yield of 6.2%. National Research pays out 46.6% of its earnings in the form of a dividend. Upbound Group pays out 73.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Upbound Group has raised its dividend for 5 consecutive years. Upbound Group is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

47.3% of National Research shares are owned by institutional investors. Comparatively, 90.3% of Upbound Group shares are owned by institutional investors. 2.0% of National Research shares are owned by company insiders. Comparatively, 2.6% of Upbound Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

National Research has a beta of 0.45, suggesting that its share price is 55% less volatile than the S&P 500. Comparatively, Upbound Group has a beta of 1.74, suggesting that its share price is 74% more volatile than the S&P 500.

Upbound Group has higher revenue and earnings than National Research. Upbound Group is trading at a lower price-to-earnings ratio than National Research, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
National Research$141.30M2.41$24.78M$1.0314.51
Upbound Group$4.32B0.33$123.48M$2.1311.73

In the previous week, Upbound Group had 3 more articles in the media than National Research. MarketBeat recorded 4 mentions for Upbound Group and 1 mentions for National Research. Upbound Group's average media sentiment score of 1.03 beat National Research's score of 0.32 indicating that Upbound Group is being referred to more favorably in the news media.

Company Overall Sentiment
National Research Neutral
Upbound Group Positive

Upbound Group has a consensus target price of $34.50, suggesting a potential upside of 38.06%. Given Upbound Group's stronger consensus rating and higher probable upside, analysts plainly believe Upbound Group is more favorable than National Research.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
National Research
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Upbound Group
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.80

Summary

Upbound Group beats National Research on 14 of the 20 factors compared between the two stocks.

Get National Research News Delivered to You Automatically

Sign up to receive the latest news and ratings for NRC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NRC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NRC vs. The Competition

MetricNational ResearchBUSINESS INFO SVC IndustryBusiness SectorNASDAQ Exchange
Market Cap$340.64M$20.45B$15.04B$9.31B
Dividend Yield3.01%1.68%2.73%4.03%
P/E Ratio14.5133.3228.1719.73
Price / Sales2.414.26570.52174.27
Price / Cash11.5218.3126.3357.96
Price / Book10.9939.026.445.67
Net Income$24.78M$508.90M$196.70M$257.79M
7 Day Performance-10.69%-1.38%0.50%0.52%
1 Month Performance-10.10%0.35%5.42%8.84%
1 Year Performance-39.30%0.68%21.87%14.18%

National Research Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NRC
National Research
2.1452 of 5 stars
$14.95
-1.0%
N/A-35.7%$340.64M$141.30M14.51490
UPBD
Upbound Group
4.9056 of 5 stars
$25.66
-2.6%
$34.50
+34.5%
-20.6%$1.52B$4.40B12.0511,970Positive News
TASK
TaskUs
1.4168 of 5 stars
$16.90
+0.7%
$17.67
+4.5%
+9.0%$1.49B$994.98M27.7048,200
GB
Global Blue Group
2.0171 of 5 stars
$7.46
-0.1%
$6.00
-19.6%
+38.8%$1.49B$545.29M20.162,160
CRTO
Criteo
4.3638 of 5 stars
$24.84
-0.3%
$46.70
+88.0%
-42.2%$1.44B$1.93B10.103,507
FLYW
Flywire
4.0585 of 5 stars
$11.92
+0.8%
$15.00
+25.8%
-36.5%$1.44B$492.14M298.001,250Analyst Revision
ASTH
Astrana Health
3.6976 of 5 stars
$24.15
-4.5%
$53.29
+120.6%
-48.5%$1.42B$2.03B33.541,900
EVH
Evolent Health
1.1141 of 5 stars
$11.64
-1.3%
$17.79
+52.8%
-40.9%$1.38B$2.55B-9.464,500
RDWR
Radware
1.888 of 5 stars
$30.25
-0.8%
$27.00
-10.7%
+50.8%$1.30B$274.88M112.041,208
PRG
Aaron's
4.5928 of 5 stars
$29.86
-2.2%
$44.83
+50.1%
-15.5%$1.23B$2.46B6.121,403News Coverage
Upcoming Earnings
Analyst Downgrade
STGW
Stagwell
2.5371 of 5 stars
$4.53
-0.7%
$9.13
+101.4%
-34.5%$1.22B$2.84B-453.0014,607

Related Companies and Tools


This page (NASDAQ:NRC) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners